Twitter Updates

    follow me on Twitter

    My Profile

    • EXPERTISE -
      Authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; issues and crisis management. Frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!

    About This Blog

    • Eye on FDA is published by Mark Senak of Fleishman-Hillard's Washington, D.C. office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of Fleishman-Hillard or its clients.

    My Favorite Dogs

    • January20063_005
      Nick and Nora

    Stats

    • eXTReMe Tracker

    Eye on FDA edrugsearch blog ranking

    • Healthcare 100

    Syndication

    « Testing Risk Management | Main | Weekly Roundup - 2/9/07 »

    February 08, 2007

    TrackBack

    TrackBack URL for this entry:
    http://www.typepad.com/services/trackback/6a00d83451bf5969e200d83463968969e2

    Listed below are links to weblogs that reference FDA/Pharma Legislative Proposals:

    » Recent Pharma Legislation from Juvan's Health Law Update
    Interested in reviewing recently introduced Pharma legislation? Well, I'd suggest that you head over to Eye on FDA, where Mark Senak provides a thorough review ofrecently introduced Pharma legislation.... [Read More]

    Comments

    Vincent S. Venturella, Ph.D., R.Ph.

    I should think that S.438 - Fair Prescription Drug Competition Act -would actually be as much of a restraint of trade as that which it is supposedly trying to prevent.
    If H.R. 331 - Drug Expiration Date Study passes, who will tell the FDA that it should rescind its policy (during NDA preparation)of allowing only real time stability data in the application and every supplement or annual report thereafter. Someone should tell the legislators that the Industry is giving the FDA only what it wants as far as expiration dating is concerned.
    H.R. 4 - Medicare Prescription Drug Price Negotiation Act of 2007 is noteworthy in that none of the negotiated proces would reach the senior population of PartD.
    S. 28 - Generics First Act of 2007 --so much for your physicians' best experience on what is best for the patient. Price is never a good barometer of success.

    Adam J. Fein

    I recall my Schoolhouse Rock well enough to know that these are not laws, but the level of bipartisan support and political rhetoric indicate significant misunderstanding of drug distribution channels. IMHO, politicians are endangering public health by opening up diversion channels for criminals.

    The importation bills (H.R. 380/S.242) expand the federal government's powers with regard to both individual U.S. states as well as foreign countries. In addition, track-and-trace is necessary but not sufficient for supply chain security. Adding insult to injury is the fact that track-and-trace technology is not nearly as advanced as these bills imply.

    See my blog for details.
    http://drugchannels.blogspot.com/search/label/Drug%20Counterfeiting

    Just my $0.02.

    Adam
    http://DrugChannels.blogspot.com

    Verify your Comment

    Previewing your Comment

    This is only a preview. Your comment has not yet been posted.

    Working...
    Your comment could not be posted. Error type:
    Your comment has been posted. Post another comment

    The letters and numbers you entered did not match the image. Please try again.

    As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

    Having trouble reading this image? View an alternate.

    Working...

    Post a comment

    Subscribe / Email Me

    Enter your email address:

    Delivered by FeedBurner

    Search

    • Google

      WWW
      eyeonfda.com

    September 2010

    Sun Mon Tue Wed Thu Fri Sat
          1 2 3 4
    5 6 7 8 9 10 11
    12 13 14 15 16 17 18
    19 20 21 22 23 24 25
    26 27 28 29 30